Adolescent and young adult oncology, version 2.2014.
The NCCN Guidelines Insights on Adolescent and Young Adult (AYA) Oncology discuss the fertility and endocrine issues that are relevant to the management of AYA patients with cancer. Fertility preservation should be an essential part in the treatment of AYA patients with cancer. The NCCN Guidelines recommend discussion of fertility preservation and contraception before the start of treatment. Oophoropexy and embryo cryopreservation are the 2 established options for fertility preservation in women. Semen cryopreservation before the start of treatment is the most reliable and well-established method of preserving fertility in men. AYA women with cancer also have unique contraception needs, depending on the type of cancer, its treatment, and treatment-related complications. Management of cancer during pregnancy poses significant diagnostic and therapeutic challenges for both the patient and the physician. AYA women diagnosed with cancer during pregnancy require individualized treatment from a multidisciplinary team involving medical, surgical, radiation, and gynecologic oncologists; obstetricians; and perinatologists.
From 1Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 2St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 3Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 4City of Hope Comprehensive Cancer Center; 5Vanderbilt-Ingram Cancer Center; 6The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 7Dana-Farber/Brigham and Women's Cancer Center; 8UCSF Helen Diller Family Comprehensive Cancer Center; 9Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 10Massachusetts General Hospital Cancer Center; 11Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; 12Roswell Park Cancer Institute; 13Stanford Cancer Institute; 14Memorial Sloan-Kettering Cancer Center; 15The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 16Moffitt Cancer Center; 17Huntsman Cancer Institute at the University of Utah; 18The University of Texas MD Anderson Cancer Center; 19Fox Chase Cancer Center; 20Duke Cancer Institute; 21University of Alabama at Birmingham Comprehensive Cancer Center; 22University of Michigan Comprehensive Cancer Center; and 23National Comprehensive Cancer Network.
Peter F
PF
Coccia
Alberto S
AS
Pappo
Jessica
J
Altman
Smita
S
Bhatia
Scott C
SC
Borinstein
Joseph
J
Flynn
A Lindsay
AL
Frazier
Suzanne
S
George
Robert
R
Goldsby
Robert
R
Hayashi
Mary S
MS
Huang
Rebecca H
RH
Johnson
Lynda Kwon
LK
Beaupin
Michael P
MP
Link
Kevin C
KC
Oeffinger
Kathleen M
KM
Orr
Damon
D
Reed
Holly L
HL
Spraker
Deborah A
DA
Thomas
Margaret
M
von Mehren
Daniel S
DS
Wechsler
Kimberly F
KF
Whelan
Brad
B
Zebrack
Dorothy A
DA
Shead
Hema
H
Sundar
D000293:Adolescent; D000328:Adult; D005260:Female; D005298:Fertility; D017408:Guidelines as Topic; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000150:complications / Q000473:pathology*; D011247:Pregnancy; D055815:Young Adult